Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Elizabeth H Kerling"'
Autor:
Byron J Gajewski, Susan E Carlson, Alexandra R Brown, Dinesh Pal Mudaranthakam, Elizabeth H Kerling, Christina J Valentine
Publikováno v:
Journal of biopharmaceutical statistics. 33(1)
We investigate the value of a two-armed Bayesian response adaptive randomization (RAR) design to investigate early preterm birth rates of high versus low dose of docosahexaenoic acid during pregnancy. Unexpectedly, the COVID-19 pandemic forced recrui
Autor:
Nicole B. Mathis, Danielle N. Christifano, D. Jill Shaddy, John Colombo, Susan E. Carlson, Ke Liao, Kathleen M. Gustafson, Elizabeth H. Kerling
Publikováno v:
Nutritional Neuroscience. 25:80-90
Introduction: Offsprings from a prenatal docosahexaenoic acid (DHA) supplementation trial, in which pregnant women were assigned to placebo or 600mg DHA/day, were followed to determine the effect of prenatal DHA supplementation on the behavior and br
Autor:
Scott A. Sands, Dinesh Pal Mudaranthakam, Lynette K. Rogers, Christina J. Valentine, Byron J. Gajewski, Sarah A. Crawford, Alexandra R. Brown, Emily DeFranco, Carl P. Weiner, Catalin S. Buhimschi, Carlson Susan E, Michael Cackovic, Elizabeth H. Kerling
Publikováno v:
EClinicalMedicine
Background Several meta analyses have concluded n-3 fatty acids, including docosahexaenoic acid (DHA), reduce early preterm birth (EPB, 0.90). Interpretation Clinicians could consider prescribing 1000 mg DHA daily during pregnancy to reduce EPB in wo
Autor:
Catalin S. Buhimschi, Dinesh Pal Mudaranthakam, Lynette K. Rogers, Emily DeFranco, Byron J. Gajewski, Alexandra R. Brown, Scott A. Sands, Michael Cackovic, Elizabeth H. Kerling, Carlson Susan E, Christina J. Valentine, Sarah A. Crawford, Carl P. Weiner
Publikováno v:
SSRN Electronic Journal.
Background: Several meta analyses have concluded n-3 fatty acids, including docosahexaenoic acid (DHA), reduce early preterm birth (0.90). Interpretation: Physicians should consider prescribing 1000 mg DHA daily during pregnancy to reduce early prete
Autor:
Susan E. Carlson, Byron J. Gajewski, Christina J. Valentine, Elizabeth H. Kerling, Carl P. Weiner, Michael Cackovic, Catalin S. Buhimschi, Lynette K. Rogers, Scott A. Sands, Alexandra R. Brown, Dinesh Pal Mudaranthakam, Sarah A. Crawford, Emily A. DeFranco
Publikováno v:
SSRN Electronic Journal.
Autor:
Kathleen M, Gustafson, Ke, Liao, Nicole B, Mathis, D Jill, Shaddy, Elizabeth H, Kerling, Danielle N, Christifano, John, Colombo, Susan E, Carlson
Publikováno v:
Nutr Neurosci
INTRODUCTION: Offspring from a prenatal docosahexaenoic acid (DHA) supplementation trial, in which pregnant women were assigned to placebo or 600mg DHA/day, were followed to determine the effect of prenatal DHA supplementation on children’s behavio
Autor:
Sibelle Alwatchi Alhayek, Susan E. Carlson, Byron J. Gajewski, John Colombo, Elizabeth H. Kerling, Kathleen M. Gustafson
Publikováno v:
Prostaglandins Leukot Essent Fatty Acids
As previously reported, intention-to-treat findings from our phase III randomized clinical trial found that a supplement of 600 mg docosahexaenoic acid (DHA)/day during the last half of pregnancy reduced the incidence of early preterm birth (ePTB
Autor:
Dinesh Pal Mudaranthakam, Susan E. Carlson, Elizabeth H. Kerling, Christina J. Valentine, Byron J. Gajewski, Alexandra R. Brown
Publikováno v:
JMIR Formative Research
Background As the cost of clinical trials continues to rise, novel approaches are required to ensure ethical allocation of resources. Multisite trials have been increasingly utilized in phase 1 trials for rare diseases and in phase 2 and 3 trials to
Publikováno v:
Prostaglandins, Leukotrienes and Essential Fatty Acids. 121:52-56
The DHA Intake and Measurement of Neural Development (DIAMOND) trial represents one of only a few studies of the long-term dose-response effects of LCPUFA-supplemented formula feeding during infancy. The trial contrasted the effects of four formulati
Autor:
Laura M. Souther, Susan E. Carlson, Debra K. Sullivan, Byron J. Gajewski, Elizabeth H. Kerling, Michael K. Georgieff
Publikováno v:
Maternal and Child Health Journal. 20:1798-1803
Objectives National surveys consistently identify iron deficiency (ID) in US children between 1 and 3 years of age, when the brain is rapidly developing and vulnerable to the effects of ID. However, controversy remains as to how best to recognize and